GOVX
GeoVax Labs, Inc. NASDAQ Listed Sep 25, 2020$0.72
+0.03%
vs $0.72
Mkt Cap $5.3M
52w Low $0.64
0.4% of range
52w High $20.00
50d MA $1.08
200d MA $3.59
P/E (TTM)
—
EV/EBITDA
—
P/B
0.0x
Debt/Equity
0.2x
ROE
-561.2%
P/FCF
-0.0x
RSI (14)
43.90
ATR (14)
$0.07
Beta
3.81
50d MA
$1.08
200d MA
$3.59
Avg Volume
221.4K
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
1900 Lake Park Drive · Smyrna, GA 30080 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | AMC | -2.16 | -0.97 | +55.1% | 0.76 | -15.9% | -4.4% | -3.9% | +0.6% | -3.0% | +6.4% | — |
| May 14, 2026 | AMC | -1.60 | -2.62 | -63.8% | 1.26 | +5.6% | -2.4% | +79.7% | -9.0% | +10.9% | +23.3% | — |
| Apr 2, 2026 | AMC | -4.71 | -2.29 | +51.3% | 1.33 | -1.5% | -6.0% | -3.2% | -2.5% | -1.7% | +6.0% | — |
| Nov 13, 2025 | AMC | -6.00 | -7.75 | -29.2% | 11.73 | -8.4% | -3.8% | -9.1% | -0.5% | +1.7% | -3.3% | — |
| Jul 28, 2025 | AMC | -0.41 | -0.35 | +14.6% | 18.50 | +8.1% | +1.6% | +1.8% | -5.9% | +0.6% | +7.1% | — |
| May 1, 2025 | AMC | -0.59 | -0.45 | +23.7% | 24.73 | -0.9% | +2.1% | +0.0% | -7.9% | -0.1% | +4.4% | — |
| Mar 27, 2025 | AMC | -0.79 | -0.30 | +62.0% | 31.75 | -0.8% | -12.6% | -4.5% | +1.9% | +9.3% | -6.8% | — |
| Nov 12, 2024 | AMC | -1.29 | -0.91 | +29.5% | 81.25 | -18.8% | -16.9% | -3.3% | -6.9% | +24.7% | -4.0% | — |
| Aug 6, 2024 | AMC | -2.57 | -1.99 | +22.6% | 45.00 | +6.7% | -1.1% | +5.1% | -0.3% | +16.3% | +15.2% | — |
| May 14, 2024 | AMC | -5.56 | -2.47 | +55.6% | 42.50 | +1.8% | +1.2% | +1.2% | -2.3% | -4.1% | -1.2% | — |
| Feb 29, 2024 | AMC | -2.78 | -13.60 | -389.2% | 64.00 | +0.4% | -0.8% | -7.5% | -8.5% | +0.0% | -2.8% | — |
| Nov 8, 2023 | AMC | -2.55 | -4.80 | -88.2% | 206.25 | -3.7% | -1.7% | -1.8% | +3.6% | -2.8% | +1.6% | — |
| Aug 9, 2023 | AMC | -2.40 | -3.30 | -37.5% | 208.95 | +0.9% | -0.8% | +0.3% | -2.8% | -0.9% | -3.1% | — |
| May 4, 2023 | AMC | -2.85 | -2.25 | +21.1% | 243.75 | -3.7% | -3.6% | +6.3% | +0.6% | +1.0% | -3.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | D. Boral Capital | Maintains | Hold → Hold | — | $1.28 | $1.26 | -1.6% | -3.9% | +0.8% | -5.6% | -2.6% | +2.6% |
| Feb 19 | D. Boral Capital | Downgrade | Buy → Hold | — | $1.39 | $1.45 | +4.3% | +12.2% | -1.9% | +6.5% | -1.8% | +3.8% |
| Jan 21 | D. Boral Capital | Maintains | Buy → Buy | — | $2.79 | $2.80 | +0.4% | +6.8% | -3.4% | +9.4% | -6.3% | -3.7% |
| Nov 19 | D. Boral Capital | Maintains | Buy → Buy | — | $10.20 | $10.50 | +2.9% | +1.7% | -3.3% | -2.3% | -3.1% | -0.2% |
| Sep 26 | D. Boral Capital | Maintains | Buy → Buy | — | $16.02 | $16.24 | +1.4% | +0.8% | -2.6% | -24.8% | +13.9% | +3.0% |
| Aug 7 | D. Boral Capital | Maintains | Buy → Buy | — | $16.52 | $16.53 | +0.1% | +1.3% | +1.4% | +0.1% | +2.8% | +5.7% |
| Jul 29 | D. Boral Capital | Maintains | Buy → Buy | — | $18.50 | $20.00 | +8.1% | +1.6% | +1.8% | -5.9% | +0.6% | +7.1% |
| Jul 17 | D. Boral Capital | Maintains | Buy → Buy | — | $18.36 | $18.50 | +0.8% | -0.5% | +4.8% | +7.2% | +0.0% | +3.8% |
| Jun 16 | D. Boral Capital | Maintains | Buy → Buy | — | $25.75 | $29.00 | +12.6% | +28.2% | -31.8% | +2.8% | +2.1% | -7.3% |
| May 2 | D. Boral Capital | Maintains | Buy → Buy | — | $24.73 | $24.50 | -0.9% | +2.1% | +0.0% | -7.9% | -0.1% | +4.4% |
| Apr 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.26 | $21.25 | -0.0% | +6.1% | -8.1% | -8.4% | +7.6% | +3.7% |
| Apr 15 | D. Boral Capital | Maintains | Buy → Buy | — | $26.75 | $19.50 | -27.1% | -20.5% | +6.1% | -8.1% | -8.4% | +7.6% |
| Apr 10 | D. Boral Capital | Maintains | Buy → Buy | — | $26.00 | $25.50 | -1.9% | -8.6% | +7.3% | +4.9% | -20.5% | +6.1% |
| Mar 28 | D. Boral Capital | Maintains | Buy → Buy | — | $31.75 | $31.50 | -0.8% | -12.6% | -4.5% | +1.9% | +9.3% | -6.8% |
| Feb 27 | D. Boral Capital | Maintains | Buy → Buy | — | $37.00 | $37.50 | +1.4% | -2.7% | +0.0% | +4.9% | +14.6% | +1.2% |
| Jan 31 | D. Boral Capital | Maintains | Buy → Buy | — | $48.75 | $50.25 | +3.1% | -2.1% | -7.3% | -1.7% | +0.0% | -1.7% |
| Jan 16 | D. Boral Capital | Maintains | Buy → Buy | — | $56.25 | $56.75 | +0.9% | -0.4% | -0.9% | +0.0% | -5.0% | +1.4% |
| Dec 18 | D. Boral Capital | Maintains | Buy → Buy | — | $56.75 | $56.75 | +0.0% | -1.3% | +3.6% | -1.3% | -3.5% | +2.3% |
| Nov 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $72.75 | $71.00 | -2.4% | -10.3% | +3.4% | +9.3% | +2.0% | -10.3% |
| Nov 19 | D. Boral Capital | Maintains | Buy → Buy | — | $75.75 | $72.50 | -4.3% | -4.0% | -10.3% | +3.4% | +9.3% | +2.0% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $65.25 | $65.75 | +0.8% | -6.9% | +24.7% | -4.0% | -10.3% | +3.4% |
| Aug 19 | Noble Capital Markets | Maintains | Outperform → Outperform | — | $176.50 | $261.25 | +48.0% | +1.3% | -20.6% | +47.0% | -12.3% | -12.7% |
| Aug 19 | EF Hutton | Maintains | Buy → Buy | — | $176.50 | $261.25 | +48.0% | +1.3% | -20.6% | +47.0% | -12.3% | -12.7% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $46.63 | $47.50 | +1.9% | +16.3% | +15.2% | +30.0% | +3.1% | +110.7% |
| Aug 7 | EF Hutton | Maintains | Buy → Buy | — | $45.00 | $48.00 | +6.7% | -1.1% | +5.1% | -0.3% | +16.3% | +15.2% |
| Jul 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $82.00 | $87.75 | +7.0% | +0.9% | -12.4% | -3.4% | +2.5% | -12.2% |
| Jun 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $27.75 | $34.00 | +22.5% | +71.2% | -0.5% | +23.3% | +30.0% | -27.4% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $199.13 | $199.13 | +0.0% | +3.6% | -2.8% | +1.6% | +0.6% | -1.3% |
| Oct 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Aug 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $218.63 | $215.81 | -1.3% | +4.1% | -5.0% | -1.4% | +2.4% | -0.3% |
| May 8 | Noble Capital Markets | Maintains | Outperform → Outperform | — | $234.97 | $228.75 | -2.6% | +6.3% | +0.6% | +1.0% | -3.2% | -1.1% |
| May 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $234.97 | $228.75 | -2.6% | +6.3% | +0.6% | +1.0% | -3.2% | -1.1% |
| Mar 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $247.50 | $247.50 | +0.0% | +4.5% | -6.2% | -4.0% | +2.4% | +2.9% |
| Mar 3 | Dawson James | Maintains | Buy → Buy | — | $270.00 | $294.41 | +9.0% | +5.6% | -6.6% | -0.0% | +4.1% | -4.9% |
| Feb 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $330.00 | $337.50 | +2.3% | -5.7% | +1.2% | -3.7% | -4.6% | -0.2% |
| Feb 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $337.50 | $333.75 | -1.1% | -2.2% | -5.7% | +1.2% | -3.7% | -4.6% |
| Feb 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $303.38 | $303.75 | +0.1% | +10.8% | +2.7% | +1.6% | -3.0% | -1.8% |
| Dec 6 | CG Capital | Maintains | Outperform → Outperform | — | $301.31 | $294.49 | -2.3% | -7.3% | +1.4% | -2.0% | -4.1% | -6.3% |
| Oct 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $327.71 | $397.50 | +21.3% | +27.0% | -12.0% | +1.1% | -4.8% | -3.7% |
| May 23 | Maxim Group | Maintains | Buy → Buy | — | $521.25 | $746.25 | +43.2% | +66.9% | -1.3% | -27.1% | +24.0% | -2.9% |
| Nov 19 | Maxim Group | Maintains | Buy → Buy | — | $1031.25 | $1050.00 | +1.8% | +0.4% | -1.0% | -0.1% | -3.7% | +0.4% |
No insider trades available.
8-K · 2.02
!! High
GeoVax Labs, Inc. -- 8-K 2.02: Earnings Results
Jul 27
8-K
GeoVax Labs, Inc. -- 8-K Filing
Jul 10
8-K
GeoVax Labs, Inc. -- 8-K Filing
Jun 17
8-K · 1.01
!! High
GeoVax Labs, Inc. -- 8-K 1.01: Material Agreement
GeoVax Labs will receive approximately $595,000 in gross proceeds from warrant exercises, with new warrants issued on similar terms, providing near-term capital but potentially diluting existing shareholders.
May 7
8-K
Unknown — 8-K Filing
GovX announced 2025 full-year results, which investors should monitor for revenue growth, profitability metrics, and guidance for 2026 that could signal whether the government contracting marketplace is accelerating or slowing.
Apr 15
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
GOVX's delayed annual report filing signals potential financial or operational distress, likely triggering investor concerns about compliance risks, delisting threats, and undisclosed problems requiring immediate investigation.
Mar 31
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
GOVX issued unregistered warrants under Reg D, diluting existing shareholders and creating future equity pressure when warrants are exercised.
Mar 31
8-K · 1.01
!! High
GeoVax Labs, Inc. New -- 8-K 1.01: Material Agreement
GeoVax Labs completed a registered direct offering at $2.31 per share, raising capital through simultaneous share and warrant sales to support operational funding and strategic initiatives.
Feb 17
Institutional (13F) — Top 4
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | 4,248 | $6K | New | Mar 2026 |
| 2 | Wells Fargo & Company/mn | 31 | $43 | New | Mar 2026 |
| 3 | Fmr Llc | 1 | $1 | New | Mar 2026 |
| 4 | Royal Bank Of Canada | 1 | — | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 3
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 12,358 | $20K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 856 | $2K | May 2026 |
| 3 | Fidelity Total Market Index Fund | 576 | $1K | May 2026 |
Valuation
Market Cap
$5.3M
Enterprise Value
-$2.51T
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00x
P/B
0.00x
P/S
—
P/FCF
-0.03x
EV/EBITDA
—
Shares Out
958K
Financials (TTM)
Revenue
$0
Net Income
-$20.4M
EBITDA
-$20.6M
Free Cash Flow
-$21.5M
Op Cash Flow
-$21.5M
EPS Basic
$-22.40
EPS Diluted
$-13.89
EPS Forward
$-16.29
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$6.34T
Total Liab.
$2.52T
Total Equity
$3.83T
Cash
$3.09T
LT Debt
$580.03B
Book Value/Sh
$3990985.38
Debt/Equity
0.22x
Current Ratio
2.74
Quick Ratio
2.74
Returns & Growth
ROE
-561.2%
ROA
-338.5%
ROIC
0.0%
Rev Growth YoY
-37.1%
EPS Growth YoY
+81.4%
Price Returns
2W
+5.4%
1M
-28.9%
3M
-41.6%
6M
-57.3%
12M
-96.2%
Technicals
52W High
$20.00
52W Low
$0.64
50d MA
$1.08
200d MA
$3.59
RSI (14)
43.90
ATR (14)
$0.07
Beta
3.81
Avg Volume
221K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$100.00
High
$100.00
Low
$100.00
Median
$100.00
Data updated apr 25, 2026 12:03pm
· Source: financialmodelingprep.com